Communications and Marketing

Communications and Marketing

Head of Communications and Marketing

Ulrike Grönefeld

Im Neuenheimer Feld 280
69120 Heidelberg
Phone: +49 6221 422854
E-Mail: u.groenefeld@dkfz.de

Press Officer

Dr. Sibylle Kohlstädt

Im Neuenheimer Feld 280
69120 Heidelberg
Phone: +49 6221 422843
E-Mail: s.kohlstaedt@dkfz.de 

Recent Press Releases

No. 19 | 21. March 2019 | by Koh

The evolution of brain tumors

The evolution of a glioblastoma schematically illustrated
© DKFZ

Scientists from the German Cancer Research Center found in a recent study that only three different genetic alterations drive the early development of malignant glioblastomas. At least one of these three cancer drivers was present in all tumors investigated. However, it is the activation of telomerase that leads to rapid growth. The tumors develop for up to seven years before they become noticeable as symptoms and are diagnosed. However, in contrast to their early development, glioblastomas, which return after therapy, share virtually no concurrent genetic alterations.

learn more

No. 18 | 14. March 2019 | by Eck

From mirror-image biology to enhanced therapeutic proteins

Hands - a prime example of mirror-image biology
© Adobe Stock

Scientists from the German Cancer Research Center (DKFZ) have succeeded in reconstructing biomolecules in their mirror-image form. The researchers' goal is to create a mirror-image artificial protein synthesis system. Their aim is to produce mirror-image therapeutic proteins, such as antibodies, which would be protected from biological breakdown in the body and do not provoke any immune response.

learn more

No. 16 | 04. March 2019 | by Eck

Protein content as a marker for response to therapy in brain cancer

On the left the conventional morphological contrast enhanced imaging of a b...
© D. Paech/DKFZ

Brain tumors vary widely in how they respond to treatment. However, early assessment of therapy response is essential in order to choose the best possible treatment for the patient. Scientists from the German Cancer Research Center (DKFZ) have now been able to show in a study using non-invasive high-resolution 7-Tesla MRI scans that the protein content of tumors correlates with response to treatment and survival.

learn more

Publications

einblick (in German only)

RSS-Feed

Subscribe to our RSS-Feed.

to top